Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose comparison for sevoflurane MAC during adult laryngeal mask placement
ChiCTR1900022281Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and sevoflurane in cholelithiasis (4 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoint: End-tidal sevoflurane concentration. Planned start May 2019; status: not yet recruiting.
02
Drugs
dexmedetomidinesevoflurane
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on ChiCTR1900022281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022281.